Pascal Geldsetzer
Pascal Geldsetzer is a researcher at Stanford University who focuses on healthcare policy and epidemiology. His recent work has provided strong evidence that the shingles vaccine, Zostavax, significantly reduces the risk of developing dementia. This groundbreaking study utilized health records from over 280,000 older adults in Wales, marking a pivotal advancement in understanding the potential protective effects of vaccinations on brain health.
Not in the pool (under ¢1).
Recent news mentions
Pascal Geldsetzer from Stanford University emphasizes the importance of the findings regarding the shingles vaccine and dementia risk.
Voldsom interesse for vaksine som gir lavere risiko for demens
Norway· 2025-12-10
Dr. Pascal Geldsetzer, assistant professor of medicine and senior author of the new study, told Fox News Digital.
Shingles vaccine may slow dementia progression in existing patients
United States· 2025-12-03
Pascal Geldsetzer is an assistant professor of medicine at Stanford University School of Medicine and the lead author of a study on vaccines and dementia.
Patru vaccinuri ce protejează împotriva unor boli ar putea scădea riscul de demență
Romania· 2025-09-28
Pascal Geldsetzer is a professor of medicine at Stanford University and the lead author of a study on vaccines and dementia risk.
4 vacinas são associadas a um menor risco de demência
Liechtenstein· 2025-09-27
Pascal Geldsetzer led the research team that found a link between the shingles vaccine and reduced risk of dementia.
‘We are able to say much more confidently that the shingles vaccine causes a reduction in dementia risk’ – The Irish Times
Ireland· 2025-04-13
Pascal Geldsetzer is an assistant professor of medicine at Stanford University School of Medicine and senior author of the study.
I’m a brain health expert - here’s why shingles vaccines may fight dementia
New Zealand· 2025-04-11
Pascal Geldsetzer is a doctor at Stanford and the lead author of the study.
Un vaccin contre le zona réduirait de 20 % le risque de démence, selon une étude américaine
France· 2025-04-08Senior study author Pascal Geldsetzer, MD, PhD, assistant professor of medicine at Stanford, said he considers these findings 'hugely important' for clinical medicine, population health and research.
Research shows link between shingles vaccine and lower dementia riskUnited States· 2025-04-04
Pascal Geldsetzer from Stanford University emphasized the significance of the findings regarding the shingles vaccine and dementia risk.
Vacina da zona pode diminuir risco de demência | Saúde
Portugal· 2025-04-04
Pascal Geldsetzer is the lead researcher of the study published in Nature regarding shingles vaccinations and dementia.
Shingles vaccinations may fight dementia
Taiwan· 2025-04-03
Pascal Geldsetzer is the lead author of the study confirming the effectiveness of the herpes vaccine against dementia.
Un ensayo fortuito constata la eficacia de la vacuna del herpes frente a la demencia
Bolivia· 2025-04-03
Pascal Geldsetzer is the lead author of the study confirming the effectiveness of the herpes vaccine against dementia.
Vacuna del herpes sería efectiva contra la demencia - Ciencia
Paraguay· 2025-04-03Dr. Pascal Geldsetzer from Stanford University stated that vaccination offers some protection against dementia.
Vaccinul care poate să combată și demența. „Femeile beneficieză cel mai mult”Romania· 2025-04-03
Pascal Geldsetzer is preparing a randomized controlled study to further investigate the findings on vaccination and dementia.
Senkt die Impfung gegen Gürtelrose das Risiko?
Switzerland· 2025-04-02
Pascal Geldsetzer is the lead author of the study that suggests the herpes zoster vaccine may reduce the risk of dementia.
Vacunarse contra el herpes zóster podría reducir el riesgo de sufrir demencia | Salud y bienestar
Spain· 2025-04-02Pascal Geldsetzer, at Stanford University, said the shingles vaccine causes a reduction in dementia risk.
Study finds strongest evidence yet that shingles vaccine helps cut dementia risk | Dementia
United Kingdom· 2025-04-02